---
title: "Biomerica Enters Service Agreement To Develop IVD Assays"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288083585.md"
description: "Biomerica, Inc. (BMRA) has entered a three-year Master Services Agreement with a private life science company to develop proprietary in vitro diagnostic (IVD) assays. The deal includes an initial development target fee exceeding $1.75 million via multiple statements of work, with automatic one-year renewals. Development activities will occur at Biomerica's FDA-licensed facility. At the time of reporting, BMRA shares were trading at $2.36, down 2.88%."
datetime: "2026-05-29T14:20:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288083585.md)
  - [en](https://longbridge.com/en/news/288083585.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288083585.md)
generator: "portal-rs"
---

# Biomerica Enters Service Agreement To Develop IVD Assays

(RTTNews) - Biomerica, Inc. (BMRA), a biomedical company and provider of Contract Development and Manufacturing Organization (CDMO) services for healthcare market, has entered into a Master Services Agreement or MSA with a private life science company to develop proprietary in vitro diagnostic (IVD) assays.

The deal offers an initial development target fee of over $1.75 million through several statements of work (SOWs).

The contract initially is for three years, with automatic one-year renewal. 

All the development activities under the agreement will be carried out at Biomerica's FDA-licensed facility. BMRA is currently trading at $2.36, down 2.88% 

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

### Related Stocks

- [BMRA.US](https://longbridge.com/en/quote/BMRA.US.md)
- [BIS.US](https://longbridge.com/en/quote/BIS.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [Biomerica CEO Zackary S. Irani reports acquisition of $50,000 common shares](https://longbridge.com/en/news/297235006.md)
- [Biomerica FY26 net sales drop 16% to $4.45 million; dividend, interest and other income more than doubled to $1.23 million](https://longbridge.com/en/news/297561919.md)
- [Biomerica Enters Securities Purchase Agreement for Private Placement With Investors](https://longbridge.com/en/news/297088565.md)
- [“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z](https://longbridge.com/en/news/297407072.md)
- [Grupa Azoty announces extraordinary shareholder meeting](https://longbridge.com/en/news/297635728.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**